Protocol ID |
Official Title |
PI Name |
Lead CRC |
Disease Site |
Phase |
CALGB-80702 ClinicalTrials.gov: NCT01150045 | A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer | S. Ghamande | Inquiries | Colon Cancer | III |